132 related articles for article (PubMed ID: 18431153)
1. Potential false positive Tc-99m sestamibi parathyroid study due to uptake in brown adipose tissue.
Wong KK; Brown RK; Avram AM
Clin Nucl Med; 2008 May; 33(5):346-8. PubMed ID: 18431153
[TBL] [Abstract][Full Text] [Related]
2. Visualization of brown adipose tissue with 99mTc-methoxyisobutylisonitrile on SPECT/CT.
Goetze S; Lavely WC; Ziessman HA; Wahl RL
J Nucl Med; 2008 May; 49(5):752-6. PubMed ID: 18413387
[TBL] [Abstract][Full Text] [Related]
3. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
5. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of anterior 180°
Cheng JL; Hsu CC; Wang PW; Sung KC; Chiu NT; Chiu LY; Huang YC
Ann Nucl Med; 2021 Feb; 35(2):203-210. PubMed ID: 33389667
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive (99m)Tc-sestamibi radioguided surgery of parathyroid adenomas.
Rubello D; Giannini S; De Carlo E; Mariani G; Muzzio PC; Rampin L; Pelizzo MR
Panminerva Med; 2005 Jun; 47(2):99-107. PubMed ID: 16210995
[TBL] [Abstract][Full Text] [Related]
9. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
[TBL] [Abstract][Full Text] [Related]
10. Brown adipose tissue: evaluation with 201Tl and 99mTc-sestamibi dual-tracer SPECT.
Higuchi T; Kinuya S; Taki J; Nakajima K; Ikeda M; Namura M; Tonami N
Ann Nucl Med; 2004 Sep; 18(6):547-9. PubMed ID: 15515758
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
[TBL] [Abstract][Full Text] [Related]
12. Uptake of Tc-99m sestamibi by brown tumors in a patient with primary hyperparathyroidism.
Muthiah A; Kalani JG; Katz DS
Clin Nucl Med; 1998 Feb; 23(2):83-5. PubMed ID: 9481494
[TBL] [Abstract][Full Text] [Related]
13. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?
Sharma J; Mazzaglia P; Milas M; Berber E; Schuster DM; Halkar R; Siperstein A; Weber CJ
Surgery; 2006 Dec; 140(6):856-63; discussion 863-5. PubMed ID: 17188131
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m sestamibi uptake in a maxillary brown tumor.
Gayed IW; Elshazly SM; Vang RS; Barron BJ; Lamki LM
Clin Nucl Med; 2001 Jan; 26(1):65-7. PubMed ID: 11139061
[TBL] [Abstract][Full Text] [Related]
15. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
[TBL] [Abstract][Full Text] [Related]
16. Assessment of brown adipose tissue activity in rats by 99mTc-sestamibi uptake.
Kyparos D; Arsos G; Georga S; Petridou A; Kyparos A; Papageorgiou E; Mougios V; Matziari C; Karakatsanis C
Physiol Res; 2006; 55(6):653-659. PubMed ID: 16497107
[TBL] [Abstract][Full Text] [Related]
17. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue.
Mehta NY; Ruda JM; Kapadia S; Boyer PJ; Hollenbeak CS; Stack BC
Arch Otolaryngol Head Neck Surg; 2005 Jun; 131(6):493-8. PubMed ID: 15967881
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
19. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
Aigner RM; Fueger GF; Lax S
Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
